GlassScriptPhysician profile
Priscilla J Ross
NPI 1336366871
$4,598.91
in general payments reported to CMS, 2019-2025
44 companies · $562 in 2025
The $562 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,108 · 2020: $664 · 2021: $808 · 2022: $671 · 2023: $232 · 2024: $553 · 2025: $562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,346.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,378.58 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $240.62 | 2020-2025 | Proclaim |
| Medtronic, INC. | $215.93 | 2021-2025 | Inceptiv |
| Nevro Corp. | $195.40 | 2019-2024 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $193.28 | 2019-2025 | Relistor |
| Globus Medical, INC. | $181.39 | 2025 | Senza |
| Abbvie INC. | $179.65 | 2021-2024 | |
| Medtronic USA, INC. | $174.55 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $169.26 | 2019-2025 | Belbuca, Nucynta |
| Forte Bio-Pharma LLC | $154.96 | 2020-2024 | Prolate, Nalocet |
| Zyla Life Sciences, INC. | $141.86 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $137.62 | 2022 | |
| Scilex Pharmaceuticals INC. | $105.74 | 2019-2022 | |
| Sentynl Therapeutics, INC. | $81.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $75.62 | 2019-2020 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priscilla Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.